Patient Profile 2: A 39-Year-Old Woman with High-Risk Stage II CRC

March 7, 2024

By John Strickler, MD
Aparna Raj Parikh, MD, MS

Opinion

Video

Stacey Cohen, MD, presents the case of a 39-year-old woman with high-risk stage II colorectal cancer, highlighting how ctDNA helped inform treatment selection.

EP: 1.Testing for MRD With ctDNA in Colorectal Cancer (CRC)

EP: 2.Platforms for Testing MRD in CRC

EP: 3.MRD Testing Practices in Colorectal Cancer

EP: 4.Patient Profile 1: A 50-Year-Old With Stage III Colorectal Cancer

EP: 5.Prospective Trial Data on MRD Testing in Early-Stage CRC

EP: 6.COSMOS-CRC-03: ctDNA and Recurrence in Colorectal Cancer

Now Viewing

EP: 7.Patient Profile 2: A 39-Year-Old Woman with High-Risk Stage II CRC

EP: 8.DYNAMIC Trial: ctDNA Analysis Guiding Adjuvant Therapy in Early-Stage CRC

EP: 9.Colorectal Cancer: Key Updates from GALAXY At ASCO GI 2024

EP: 10.Rationale and Study Design of CIRCULATE-NORTH AMERICA in CRC

EP: 11.Initial Results from Phase 2 COBRA Study in Colorectal Cancer

EP: 12.Patient Profile 3: A 62-Year-Old Woman with Colon Cancer

EP: 13.The Study Design and Early Findings from the INTERCEPT Study in CRC

EP: 14.BESPOKE CRC: The Impact of ctDNA-Guided Therapy in CRC

EP: 15.Future Perspectives on MRD Testing in Colorectal Cancer

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!